Physician profile
Gregory Condos
NPI 1225378110
$7,434.70
in general payments reported to CMS, 2019-2025
17 companies · $460 in 2025
The $460 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,201 · 2020: $425 · 2021: $1,527 · 2022: $948 · 2023: $2,367 · 2024: $507 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,434 · Travel and Lodging: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,434.39 |
| Travel and Lodging | $899.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,143.35 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $1,851.41 | 2019-2025 | Mitraclip, Dragonfly Opstar, Aveir |
| Medtronic, INC. | $943.66 | 2021-2024 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $503.78 | 2020-2024 | Lifevest |
| Medtronic Vascular, INC. | $479.73 | 2019-2020 | |
| Abiomed | $460.53 | 2019-2025 | |
| Shockwave Medical, INC | $306.10 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $170.69 | 2022 | |
| Ekos Corporation | $138.89 | 2019 | |
| Pfizer INC. | $117.40 | 2019 | |
| Boston Scientific Corporation | $93.97 | 2023-2025 | Wolverine Coronary Cutting Balloon, Ekosonic |
| Inari Medical, INC. | $71.23 | 2021 | |
| Cvrx, INC. | $43.83 | 2022 | |
| Chiesi USA, INC. | $35.48 | 2021-2025 | Kengreal |
| Stryker Corporation | $30.83 | 2025 | Clottriever Bold Catheter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $25.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Condos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.